Mammary Cell News Volume 12.49 | Dec 17 2020

    0
    90







    2020-12-17 | MCN 12.49


    Mammary Cell News by STEMCELL Technologies
    Vol. 12.49 – 17 December, 2020
    TOP STORY

    Selective Glutamine Metabolism Inhibition in Tumor Cells Improves Anti-Tumor T Lymphocyte Activity in Triple-Negative Breast Cancer

    Investigators report an inverse correlation between glutamine metabolic genes and markers of T cell-mediated cytotoxicity in human basal-like breast cancer patient datasets, with increased glutamine metabolism and decreased T cell cytotoxicity associated with poor survival.
    [Journal of Clinical Investigation]

    AbstractFull Article

    Request a free copy of the Growing Organoids from Stem Cells Wallchart
    PUBLICATIONSRanked by the impact factor of the journal

    BCL(X)L and BCL2 Increase the Metabolic Fitness of Breast Cancer Cells: A Single-Cell Imaging Study

    Scientists found that BCL2 and BCL(X)L increased the metabolic robustness of MCF7 cells and that this was associated with increased mitochondrial NAD(P)H and ATP levels.
    [Cell Death & Differentiation]

    Abstract

    Regulatory T Cells Support Breast Cancer Progression by Opposing IFN-γ-Dependent Functional Reprogramming of Myeloid Cells

    Researchers demonstrated that regulatory T cell ablation-dependent anti-tumor effects in murine breast cancer required intratumoral recruitment of CCR2+ inflammatory monocytes, which primarily differentiated into tumor-associated macrophages, and led to reprogramming of their function in an IFN-γ-dependent manner.
    [Cell Reports]

    Full ArticlePress ReleaseGraphical Abstract

    FZD5 Contributes to TNBC Proliferation, DNA Damage Repair and Stemness

    Loss and gain of function studies revealed that FZD5 contributed to TNBC cell G1/S transition, DNA replication, DNA damage repair, survival, and stemness. Mechanistically, transcription factor FOXM1, which promoted BRCA1 and BIRC5 transcription, acted as a downstream effecter of FZD5 signaling.
    [Cell Death & Disease]

    Full Article

    Distinct Photo-Oxidation-Induced Cell Death Pathways Lead to Selective Killing of Human Breast Cancer Cells

    Through lipidomics and biochemical approaches, scientists demonstrated that photodynamic therapy efficiency and specificity relied on polyunsaturated fatty acid-enriched membranes and on the better capacity to deal with photo-oxidative damage displayed by non-tumorigenic cells.
    [Cell Death & Disease]

    Full Article

    OXER1 and RACK1-Associated Pathway: A Promising Drug Target for Breast Cancer Progression

    The authors provided evidence that nandrolone inhibited breast cancer cell proliferation and migration by antagonizing the PI3K/Akt/NF-κB signaling pathway, which eventually resulted in RACK1 downregulation.
    [Oncogenesis]

    Full Article

    Differential Metabolic Responses in Breast Cancer Cell Lines to Acidosis and Lactic Acidosis Revealed by Stable Isotope Assisted Metabolomics

    Scientists investigated the metabolomic changes in triple negative and luminal subtype breast cancer cell lines in response to acidosis and lactic acidosis.
    [Scientific Reports]

    Full Article

    Environmental Control of Mammary Carcinoma Cell Expansion by Acidification and Spheroid Formation In Vitro

    Researchers evaluated the fundamental effects of environmental acidification on mammary carcinoma cells in standard 2D cultures and 3D spheroids.
    [Scientific Reports]

    Full Article

    YY1-Mediated Long Non-Coding RNA Kcnq1ot1 Promotes the Tumor Progression by Regulating PTEN via DNMT1 in Triple Negative Breast Cancer

    The authors identified the roles of YY1-mediated long non-coding RNA Kcnq1ot1 in TNBC. The paired samples of tumor tissues and adjacent tissues were collected to determine YY1, lncRNA Kcnq1ot1, and PTEN expression using RT-qPCR and Western blot analysis followed by analysis of the relationship between them and patient survival.
    [Cancer Gene Therapy]

    Abstract

    Explore the STEMCELL digital calendar to discover conferences, podcasts, webinars, and more!
    REVIEWS

    Modulating the Crosstalk between the Tumor and the Microenvironment Using SiRNA: A Flexible Strategy for Breast Cancer Treatment

    Investigators describe recent efforts in developing small interfering RNA (siRNA) therapeutics for the treatment of breast cancer, with particular emphasis on tumor microenvironment (TME) regulation. They focus on studies that adapt siRNA design to reprogram/re-educate the TME and eradicate the interplay between cancer cells and TME.
    [Cancers]

    Full Article

    The Long Non-Coding RNA Landscape in Triple-Negative Breast Cancer

    The authors review the biological characteristics of long non‐coding RNAs (lncRNAs), and present the current state of knowledge concerning the expression, function and regulation of lncRNAs in TNBC.
    [Cell Proliferation]

    Full Article

    INDUSTRY AND POLICY NEWS

    Zai Lab Partner MacroGenics Announces FDA Approval of MARGENZA for Patients with Pretreated Metastatic HER2-Positive Breast Cancer

    Zai Lab Limited announced that the FDA has approved MARGENZA, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens, at least one of which was for metastatic disease.
    [Zai Lab Limited]

    Press Release

    Seagen Announces Positive CHMP Opinion for TUKYSA® (tucatinib) for the Treatment of Patients with Locally Advanced or Metastatic HER2-Positive Breast Cancer

    Seagen Inc. announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion recommending the approval of TUKYSA® in combination with trastuzumab and capecitabine for the treatment of adult patients with HER2-positive locally advanced or metastatic breast cancer who have received at least two prior anti-HER2 treatment regimens.
    [Seagen Inc.]

    Press Release

    FEATURED EVENT

    ISSCR: Vision 2030 A Forecast for the Field

    January 7 – 8, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Research Fellow – Breast Cancer

    Dana-Farber Cancer Institute – Boston, Massachusetts, United States

    Postdoctoral Associate – Tumor Immune Microenvironment

    University of Florida – Gainesville, Florida, United States

    Postdoctoral Position – Breast Cancer

    University of Iowa Carver College of Medicine – Iowa City, Iowa, United States

    Postdoctoral Fellow – Breast Cancer Immuno-Oncology Research

    Salk Institute of Biological Studies – La Jolla, California, United States

    Research Assistant – Breast Cancer

    King’s College London – London, England, United Kingdom

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Science News Mammary Cell News Archives Contact Us
    Mammary Cell News Twitter